Dr. Lloyd Damon, MD

Claim this profile

University of California, San Francisco

Studies Acute Myelogenous Leukemia
Studies Acute Myeloid Leukemia
4 reported clinical trials
7 drugs studied

Area of expertise

1

Acute Myelogenous Leukemia

Lloyd Damon, MD has run 3 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:

CEBPA negative
NPM1 negative
IDH positive
2

Acute Myeloid Leukemia

Lloyd Damon, MD has run 3 trials for Acute Myeloid Leukemia. Some of their research focus areas include:

CEBPA negative
NPM1 negative
IDH positive

Affiliated Hospitals

Image of trial facility.

University Of California, San Francisco

Image of trial facility.

UCSF Comprehensive Cancer Center

More about Lloyd Damon, MD

Clinical Trial Related

5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 0 Active Clinical Trials

Treatments Lloyd Damon, MD has experience with

  • Liposome-encapsulated Daunorubicin-Cytarabine
  • CPX-351
  • Glasdegib
  • Blinatumomab
  • Pembrolizumab
  • Enasidenib Mesylate

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Lloyd Damon, MD specialize in?

Is Lloyd Damon, MD currently recruiting for clinical trials?

Are there any treatments that Lloyd Damon, MD has studied deeply?

What is the best way to schedule an appointment with Lloyd Damon, MD?

What is the office address of Lloyd Damon, MD?

Is there any support for travel costs?